Important pharmacy news and late-breaking industry information updated daily.
As foreign-made generic blood-pressure medications tainted with probable carcinogens continue to be recalled, U.S. lawmakers are seeking more information about regulators' capacity to protect the nation's drug supply. House Energy and Commerce Committee Chairman Rep. Frank Pallone (D-NJ) and Rep.
The Infectious Diseases Society of America (IDSA), along with other organizations, released a draft of new guidelines for the prevention, diagnosis, and treatment of Lyme disease.
FDA approved on Thursday eculizumab (Soliris—Alexion Pharmaceuticals) injection for I.V. use for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive. The rare autoimmune disease of the central nervous system primarily affects the optic nerves and spinal cord.
FDA approved on Wednesday dupilumab (Dupixent—Regeneron Pharmaceuticals) for the treatment of adults with nasal polyps accompanied by chronic rhinosinusitis.
San Francisco's Board of Supervisors voted unanimously Tuesday to ban the sale and distribution of e-cigarettes in the city, a move that seeks to curb what experts have described as a nicotine epidemic among teenagers.
A small study could have big insights for opioid use after surgery. Greater opioid quantity for postsurgery patients has been associated with the development of addiction, noted authors of a study published in JAMA on June 25. Their study looked at whether reducing the number of opioid tablets prescribed after anterior cruciate ligament (ACL) knee surgery at a single academic ambulatory surgery center would reduce postoperative use, and if preoperative opioid-use education could reduce it even more.
President Donald Trump on Monday signed an executive order intended to give Americans more information about the cost and quality of health care services to help them comparison shop before they get care.
With cases of measles continuing to climb in the United States and Americans embarking on summer travel, CDC is reminding health care practitioners and the public about MMR vaccination recommendations for international travelers as well those traveling to U.S. areas with ongoing measles outbreaks.
FDA approved a new treatment, romosozumab-aqqg (Evenity—Amgen), for osteoporosis in postmenopausal women at high risk of fracture, such as those who have a history of osteoporotic fracture or have multiple risk factors for fracture, as well as patients who are intolerant to or have not had success with other osteoporosis therapies. Romosozumab-aqqg is a humanized monoclonal antibody that increases new bone formation by blocking the effects of sclerostin, a protein that inhibits bone formation.
FDA has expanded the indication for tezacaftor/ivacaftor (Symdeko—Vertex) tablets for the treatment of patients aged 6 years and older with cystic fibrosis who have two copies of the F508del mutation in the CF transmembrane conductance regulator gene or at least one mutation that is responsive to tezacaftor/ivacaftor.